Your browser doesn't support javascript.
loading
CD8 engineered cytotoxic T cells reprogram melanoma tumor environment.
Leignadier, Julie; Favre, Stephanie; Luther, Sanjiv A; Luescher, Immanuel F.
Afiliación
  • Leignadier J; Ludwig Center for Cancer Research, University of Lausanne , Epalinges, Switzerland.
  • Favre S; Department of Biochemistry, University of Lausanne , Epalinges, Switzerland.
  • Luther SA; Department of Biochemistry, University of Lausanne , Epalinges, Switzerland.
  • Luescher IF; Ludwig Center for Cancer Research, University of Lausanne , Epalinges, Switzerland.
Oncoimmunology ; 5(3): e1086861, 2016 Mar.
Article en En | MEDLINE | ID: mdl-27141342
Cytotoxic T lymphocytes (CTL) from CD8ß-deficient mice have powerful FasL-mediated cytotoxicity and IFNγ responses, but ablated Ca2+ and NFAT signaling, which can be restored by transduction with CD8ß. Upon infection with lymphocytic choriomeningitis virus (LCMV), these cells yielded GP33-specific CTL (CD8ßR) that exhibited high FasL/Fas-mediated cytotoxicity, IFNγ CXCL9 and 10 chemokine responses. Transfer of these cells in B16-GP33 tumor bearing mice resulted in (i) massive T cell tumor infiltration, (ii) strong reduction of myeloid-derived suppressor cells (MDSCs), regulatory T cells (Treg) and IL-17-expressing T helper cells, (iii) maturation of tumor-associated antigen-presenting cells and (iv) production of endogenous, B16 melanoma-specific CTL that eradicated the tumor long after the transferred CD8ßR CTL perished. Our study demonstrates that the synergistic combination of strong Fas/FasL mediated cytotoxicity, IFNγ and CXCL9 and 10 responses endows adoptively transferred CTL to reprogram the tumor environment and to thus enable the generation of endogenous, tumoricidal immunity.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2016 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2016 Tipo del documento: Article País de afiliación: Suiza
...